Cargando…

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries

Background: Comprehensive transgender care involves a multidisciplinary team of primary care providers, mental health providers (MHPs), endocrinologists and surgeons. Management of gender dysphoria (GD) includes hormonal and surgical treatment, with the latter being irreversible. Mental health evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korpaisarn, Sira, Modzelewski, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550762/ http://dx.doi.org/10.1210/js.2019-MON-195

Ejemplares similares

MON-198 Feminizing Regimen Requirements in Transgender Females Following Orchiectomy
por: Korpaisarn, Sira, et al.
Publicado: (2019)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand
por: Ittiphisit, Sakditat, et al.
Publicado: (2022)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

“It Wasn’t for the Sake of Me and My Mental Health”: Transgender People’s Perspective on the Role of Mental Health Providers in Initiating Gender-Affirming Hormones - a Qualitative Study
por: Maksutova, Mariam, et al.
Publicado: (2021)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

MON-194 Multidisciplinary Care for Adult Transgender/Gender Non-binary Patients: A Novel Healthcare Delivery Model Centered within the Endocrinology Clinic
por: Iwamoto, Sean, et al.
Publicado: (2019)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

The Role of the Endocrinologist in the Gender Adequacy Process and the Barriers for Adequate Transgender Health Care
por: Saliba, Alexandra
Publicado: (2021)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

Reinforcing or Disrupting Gender Affirmation: The Impact of Cancer on Transgender Embodiment and Identity
por: Ussher, Jane M., et al.
Publicado: (2023)

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters
por: Pulsiano, Sune Wolf, et al.
Publicado: (2022)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

MON-191 Body Composition and Mineral Density in Transgender Patients in Brazil: A Retrospective Cohort
por: Mattar, Najla, et al.
Publicado: (2019)

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

MON-192 Improving Transgender Care through Comprehensive Wellness Program in the Endocrine Division: First Year Experience
por: Sajan, Alen, et al.
Publicado: (2019)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale
por: Sevelius, Jae M., et al.
Publicado: (2021)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

MON-224 Congenital Hypogonadotropic Hypogonadism: Features and Genetics of 60 Females Patients
por: Fasciglione, Elsa, et al.
Publicado: (2019)

Integrated and Gender-Affirming Transgender Clinical Care and Research
por: Reisner, Sari L., et al.
Publicado: (2016)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

MON-393 Evaluation of Bone Mass in Transgender Women After Gender Affirming Surgery - a Pilot Study
por: Fighera, Tayane Muniz, et al.
Publicado: (2020)

Impact of gender-affirming treatment on bone health in transgender and gender diverse youth
por: Ciancia, Silvia, et al.
Publicado: (2022)

Age-Related Differences for Male-to-Female Transgender Patients Undergoing Gender-Affirming Surgery
por: Zavlin, Dmitry, et al.
Publicado: (2019)

Magnetic Resonance Spectroscopy in Gender Dysphoria
por: Collet, Sarah Marie, et al.
Publicado: (2021)

MON-035 Does Androgen Exposure Result in Germline Transmission of PCOS-Like Phenotypes and Can It Be Reversed?
por: Lu, Haojiang, et al.
Publicado: (2020)

Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022)

Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones
por: Taylor, Julia, et al.
Publicado: (2023)

SUN-LB8 Cross Sex Hormone Therapy and Breast Cancer in Transgender Male to Female
por: Eldin, Randa Sharag, et al.
Publicado: (2020)

Gender Identity and Gender Role in DSD Patients Raised as Females: A Preliminary Outcome Study
por: Ercan, Oya, et al.
Publicado: (2013)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5mnm1e2f35qqut0hneh7t22dtt